Fundraising Fox
Inventisbio
Shanghai, CN · Founded 2013 · 32 employees on LinkedIn · 4 known investors
Find your way into Inventisbio
Sign up to find every way you can get introduced to Inventisbio
- Your email: who you already know at Inventisbio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inventisbio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
InventisBio is a China-based drug discovery company developing patent-protected small-molecule targeted therapies for oncology and metabolic diseases. Its pipeline addresses solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as hyperuricemia/gout and autoimmune conditions like psoriasis.
Founders & leadership
Inventisbio was founded in 2013 by Xing Dai and Yaolin Wang.
Investors · 4
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Inventisbio do?
- InventisBio is a China-based drug discovery company developing patent-protected small-molecule targeted therapies for oncology and metabolic diseases. Its pipeline addresses solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as hyperuricemia/gout and autoimmune conditions like psoriasis.
- Who founded Inventisbio?
- Inventisbio was founded by Xing Dai, Yaolin Wang in 2013.
- Who are Inventisbio's investors?
- Inventisbio's investors include LAV, Lilly Asia Ventures, OrbiMed, Qiming Venture Partners.
- Where is Inventisbio headquartered?
- Inventisbio is headquartered in Shanghai, CN.